Biosimilars and Sustainability: Best Value-Driven Practice
All medicines are made of either small molecules or large molecules. Biologics are advanced therapeutic drugs made of living cells, sugars, proteins, tissues, or a mixture of these. Biosimilars as follow-on biologics are game-changers to reduce patient and payers’ health bills. Biosimilars are made of large molecules and living cells. They show similar pharmacokinetics (P.K.) and […]